Anzeige Anzeige: ID Berlin GmbH ×

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina myDRG Stellenmarkt Gesundheitswesen

« Qualitätsbeurteilungs-Richtlinie Kernspintomographie | Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina | Verordnungshäufigkeit von Biosmilars der TNF alpha Inhibitoren »

 

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina (GlobeNewswire).

Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Jan. 31, 2020 Neovasc, Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement...
- - - - - - - - - - -



erschienen am Freitag, 31.01.2020
Anzeige Anzeige: ID GmbH ×